On the recordJuly 19, 2011
So it appears that the failure of this product is not due to 510(k) process but to regulatory inaction by our own FDA.
Source
congress.govEditor's note · Context
Gingrey argues that regulatory inaction, not the 510(k) process, caused issues with medical devices.
Share & report
More from Phil Gingrey
Jun 3, 2013
Our Secretary of State has made it abundantly clear to me that this amendment is not necessary, and that the EAC indeed has outlived its usefulness.
Mar 12, 2013
We're afraid to grow. The lack of information is creating fear, and it's not good for the economy.
Jun 3, 2013
But, you know, here we are 50 years later, these States, and one of them is mine, the great State of Georgia, is far, far beyond that, and yet we are under section 5 of the Voting Rights Act for another 25 years.
Other voices in this conversation
